Počet záznamů: 1  

Discovery and validation of 2-styryl substituted benzoxazin-4-ones as a novel scaffold for rhomboid protease inhibitors

  1. 1.
    SYSNO ASEP0490090
    Druh ASEPJ - Článek v odborném periodiku
    Zařazení RIVJ - Článek v odborném periodiku
    Poddruh JČlánek ve WOS
    NázevDiscovery and validation of 2-styryl substituted benzoxazin-4-ones as a novel scaffold for rhomboid protease inhibitors
    Tvůrce(i) Goel, P. (DE)
    Jumpertz, T. (DE)
    Tichá, Anežka (UOCHB-X) ORCID, RID
    Ogorek, I. (DE)
    Mikles, David C. (UOCHB-X)
    Hubálek, Martin (UOCHB-X) RID, ORCID
    Pietrzik, C. U. (DE)
    Stříšovský, Kvido (UOCHB-X) RID, ORCID
    Schmidt, B. (DE)
    Weggen, S. (DE)
    Zdroj.dok.Bioorganic and Medicinal Chemistry Letters. - : Elsevier - ISSN 0960-894X
    Roč. 28, č. 8 (2018), s. 1417-1422
    Poč.str.6 s.
    Jazyk dok.eng - angličtina
    Země vyd.GB - Velká Británie
    Klíč. slovarhomboid proteases ; intramembrane proteases ; benzoxazinones ; molecular docking ; inhibition
    Vědní obor RIVCE - Biochemie
    Obor OECDBiochemistry and molecular biology
    CEPLK11206 GA MŠMT - Ministerstvo školství, mládeže a tělovýchovy
    LO1302 GA MŠMT - Ministerstvo školství, mládeže a tělovýchovy
    Institucionální podporaUOCHB-X - RVO:61388963
    UT WOS000429408300029
    EID SCOPUS85042086167
    DOI10.1016/j.bmcl.2018.02.017
    AnotaceRhomboids are intramembrane serine proteases with diverse physiological functions in organisms ranging from archaea to humans. Crystal structure analysis has provided a detailed understanding of the catalytic mechanism, and rhomboids have been implicated in various disease contexts. Unfortunately, the design of specific rhomboid inhibitors has lagged behind, and previously described small molecule inhibitors displayed insufficient potency and/or selectivity. Using a computer-aided approach, we focused on the discovery of novel scaffolds with reduced liabilities and the possibility for broad structural variations. Docking studies with the E. coli rhomboid GlpG indicated that 2-styryl substituted benzoxazinones might comprise novel rhomboid inhibitors. Protease in vitro assays confirmed activity of 2-styryl substituted benzoxazinones against GlpG but not against the soluble serine protease alpha-chymotrypsin. Furthermore, mass spectrometry analysis demonstrated covalent modification of the catalytic residue Ser201, corroborating the predicted mechanism of inhibition and the formation of an acyl enzyme intermediate. In conclusion, 2-styryl substituted benzoxazinones are a novel rhomboid inhibitor scaffold with ample opportunity for optimization.
    PracovištěÚstav organické chemie a biochemie
    Kontaktasep@uochb.cas.cz ; Kateřina Šperková, Tel.: 232 002 584 ; Jana Procházková, Tel.: 220 183 418
    Rok sběru2019
Počet záznamů: 1  

  Tyto stránky využívají soubory cookies, které usnadňují jejich prohlížení. Další informace o tom jak používáme cookies.